CJC-1295 (no DAC) COA and Batch Review Notes: practical notes on ordering CJC-1295 (no DAC) (5mg / 10mg) for Growth Research work through sulanpeptide.vip.
CJC-1295 (no DAC), also known as modified GRF (1-29), is a synthetic GHRH analog peptide used in laboratory research on growth-hormone-axis signaling, receptor activation, and short-acting peptide analog behavior without DAC-mediated albumin binding.
Structure–activity studies compare amino-acid substitutions at positions 1–29 for GHRH receptor selectivity versus other class B GPCRs. Perifusion systems measuring GH burst amplitude and frequency are widely cited when evaluating non-DAC GHRH analogs.
Growth-axis research differentiates DAC and non-DAC formats when designing experiments that require discrete GH pulses versus sustained elevation models. Modified GRF(1-29) without DAC preserves shorter half-life suitable for pulse-mimicking perfusion experiments on pituitary cells.
Cross-check CAS 863288-34-0 and purity target ≥ 99.0%; archive approved PDFs with internal sample IDs. Janoshik records for CJC-1295 (no DAC), when listed at sulanpeptide.vip/coa, should be verified by task number and unique key before sample release.
COA review: Match COA product name, lot, test date, and HPLC purity to vial labels for CJC-1295 (no DAC).
Catalog identifiers for CJC-1295 (no DAC): CAS 863288-34-0, Formula: C152H252N44O42. MW 3367.9 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Request method details on CJC-1295 (no DAC) COA if purity is reported without chromatogram context.
Migration and receptor assays for CJC-1295 (no DAC) are sensitive to degradation—confirm lot purity before release.
Chromatographic context on CJC-1295 (no DAC) COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details. Archive CJC-1295 (no DAC) COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
Janoshik-verified CJC-1295 (no DAC) batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status. Migration and signaling assays using CJC-1295 (no DAC) are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone.
COA review for CJC-1295 (no DAC) starts with identity: product name, lot, and specification (5mg / 10mg) must match the vial label character-for-character. QA teams then confirm CAS 863288-34-0 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Migration and signaling assays using CJC-1295 (no DAC) are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone. COA review for CJC-1295 (no DAC) starts with identity: product name, lot, and specification (5mg / 10mg) must match the vial label character-for-character. QA teams then confirm CAS 863288-34-0 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Janoshik-verified CJC-1295 (no DAC) batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
CJC-1295 (no DAC) from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.